GÖTEBORG, Sweden & TREVOSE, Pa.--(BUSINESS WIRE)--Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare diseases, today announced an update on 2015 half-year corporate progress.
Help employers find you! Check out all the jobs and post your resume.